← Open Payments lookup

DANIEL NAVARRO: Open Payments

NPI 1699033092 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,422 in 11 payments from 9 companies in 2025. Trend: 2023 $177 · 2024 $484 · 2025 $1,422

Food & beverage: $1,422
CompanyPaymentsAmount
Gilead Sciences, Inc.2$265
Otsuka America Pharmaceutical, Inc.2$240
Neurocrine BioSciences, Inc.1$175
Daiichi Sankyo Inc.1$135
Vanda Pharmaceuticals Inc.1$123
E.R. Squibb & Sons, L.L.C.1$122
KYOWA KIRIN, INC.1$122
Abbott Laboratories1$121
ViiV Healthcare Company1$120

Products named: REXULTI, INGREZZA, INJECTAFER, Epclusa, FANAPT, COBENFY, FREESTYLE LIBRE 3, APRETUDE.

Industry payments across NV — which companies pay providers there.